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Multiple sclerosis (MS) is an unpredictable con-dition both with respect to alternating exac-erbation and remission of symptoms and 
variant symptom patterns.1,2 Studies show anxiety 
regarding what the future holds3 and high levels of 
depression and uncertainty in MS patients when they 
are compared to patients with other chronic diseases.4 
MS-related depressive symptoms could be a function of 
prior disease-related impairment, life stress, and possi-
ble escape avoidance coping.5 Some MS patients expe-
rience conventional disease- and symptom-modifying 
drugs as having little influence on symptoms, func-
tioning, or quality of life, while commonly experienc-
ing adverse effects.6-8 Between 27% and 100%9 of MS 
patients use complementary and alternative medicine 
(CAM) to treat and live better with their symptoms. 
The Cochrane Collaboration defines CAM as
a broad domain of healing resources that encom-
passes all health systems, modalities and practic-
es, and their accompanying theories and beliefs, 
other than those intrinsic to the politically domi-
nant health system of a particular society or cul-
ture in a given historical period. CAM includes 
all such practices and ideas self-defined by their 
users as preventing or treating illness or promot-
ing health and well-being.10(p693) 
The RegisTRy of exCePTional CouRses of Disease
This case report was selected from the Registry of 
Exceptional Courses of Disease (hereafter referred to as 
“the Registry”). The Registry includes Scandinavian 
patient-defined, self-reported positive and negative excep-
tional courses of disease related to the use of CAM. To be 
included, the patients must have or have had a disease or 
health problem, must have experienced what they per-
ceive to be exceptionally positive or exceptionally nega-
tive health effects, and must relate these health effects to 
the use of CAM. In a “best case,” the patient experiences 
reduced disease symptoms or full recovery.a,11-13 
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aBsTRaCT
Chronically ill people are frequent 
users of complementary and alter-
native medicine (CAM). Some 
patients experience great benefits 
from their use of CAM, like patient 
“XX” in this case report. XX was 
diagnosed with secondary progres-
sive multiple sclerosis in 2004 and 
has reported a “best case” after the 
use of Dr Birgitta Brunes’ unconven-
tional treatment. The patient 
reports that many of her symptoms 
that, according to her neurologist, 
were irreversible are gone or have 
been greatly reduced. Such patient-
defined “best cases” related to the 
use of CAM should be further 
explored to optimize and safeguard 



















Las personas que padecen enferme-
dades crónicas son usuarios frecuent-
es de la medicina complementaria y 
alternativa (CMA, por sus siglas en 
inglés). Algunos pacientes experi-
mentan grandes beneficios a partir del 
uso de CAM, como es el caso de la 
paciente “XX” que se analiza en este 
caso clínico. Dicha paciente fue diag-
nosticada con esclerosis múltiple 
secundaria progresiva en el año 2004 
y fue registrada como el “mejor caso”, 
luego de recibir el tratamiento no 
convencional de la Dra. Birgitta 
Brunes. La paciente reconoció que 
muchos de sus síntomas, que según su 
neurólogo eran irreversibles, desapa-
recieron o se redujeron en gran medi-
da. Dicha paciente, catalogada como 
el “mejor caso” relacionado con el uso 
de CAM, debe ser sujeta a análisis más 
profundos para optimizar y resguar-
dar las decisiones que toman los paci-
entes sobre el tratamiento y los resul-
tados del mismo.
a For more information on the Registry, see pages 70-75 of this issue.
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As of October 1, 2011, 72 patients diagnosed with 
MS were included in the Registry, all reporting “best 
cases.” Acupuncture, nutritional therapy, reflexology, 
herbs and food supplements, homeopathy, massage/
aromatherapy, and spiritual healing were the most 
frequently used CAM modalities among these patients. 
Case PResenTaTion 
Context and goal
We here present a self-defined “best case” of MS. 
The presentation is based on the Registry question-
naire, medical records, a medical assessment, and an 
in-depth interview. The goal is to describe a patient-
defined “exceptionally positive” course of MS as seen 
from both a patient and medical perspective. 
Medical, social, and family history
“XX” is a 46-year-old married Norwegian woman 
with several children. She is a university graduate who 
had been working full time for some time after being 
diagnosed but is now on a 100%-disability pension. 
Approximately 28 years ago, she had a facial paralysis 
on her right side from which she fully recovered after 1 
to 2 months. About 15 years ago, she experienced 2 
episodes of herpes zoster (shingles). She has otherwise 
been healthy. Several of XX’s close relatives also have 
been diagnosed with MS.
Presenting Condition 
When she was in her 20s, XX was diagnosed with 
probable MS but was not herself informed of the diag-
nosis. A few years later, she experienced partial loss of 
sensation in her legs and was finally officially diag-
nosed with secondary progressive MS at the age of 41 
years. Her main symptoms were fatigue, problems with 
leg coordination after experiencing strain for some 
time, periodical memory problems, and urge-character-
ized urination. Subsequently, XX experienced severe 
fatigue and reduced sensation in her feet, legs, and fin-
gers. She even found brushing her teeth exhausting. 
She continued to have problems holding and emptying 
the bladder and also experienced depression. 
Treatment
No conventional treatment was provided by doc-
tors within the conventional healthcare system. 
Within a year after being diagnosed, XX discovered the 
treatment given by Birgitta Brunes (BB), MD, and 
decided to participate in one of BB’s courses. 
BB is a Swedish medical doctor who herself suffers 
from MS and who has worked with treatment and reha-
bilitation of MS patients since 1994. She has developed a 
systematic approach to symptom alleviation, which she 
presented in a book14 published in the Scandinavian 
countries. With her colleagues, she gives courses for MS 
patients that usually last 4 days and focus on psychologi-
cal factors (emotions, stress, etc), social factors, and medi-
cal treatment. These elements are combined in a treat-
ment plan individually adapted for each patient.
BB does not consider her treatment as CAM per 
se.15 Her theory is based on conventional medical 
knowledge and practical experience from many years 
of working as a general practitioner. The treatment is 
only considered alternative in relation to the prevail-
ing medical understanding of the cause and treatment 
of MS. The intention is not to heal MS but to alleviate 
MS symptoms.
The treatment rests on 3 pillars:
1. Neurotransmitters (noradrenaline, dopamine, ace-
tylcholine, serotonin), vitamin B12, and amino 
acids adjusted according to individual need; 
2. detoxification (for instance, removal of amalgam 
or elimination of toxic environmental fac-
tors)14,15; and 
3. Psychotherapeutic treatment of basic psychologi-
cal traits. 
xx’s individualized Treatment 
use and adjustment of Medication and sup-
plements. After careful self-testing, XX has found the 
suitable dosage for the different medications, and she is 
making necessary adjustments as time passes. Her cur-
rent intake of medication and supplements include 
lofepramine (a tricyclic antidepressant) plus tablets 
containing norepinephrine to prevent urge inconti-
nence. She asserts that these drugs also give her energy. 
She also takes acetylcholine and anticholinesterase in 
addition to phosphatidylcholine and lecithin from the 
health food store, which she contends create “heat” and 
help her empty the bladder and intestines. The intake of 
serotonin tablets and 5-hydroxytryptophan (5-HTP) 
from the health food store  help her keep a brighter out-
look on life and to be positive, sleep well, and not worry 
about the future and her illness. At the same time, she 
takes specially adapted amino acids for MS patients that 
attend to the muscles while she is not using them. 
Detoxification. XX had her 8 amalgam fillings 
removed over a period of 2 years. To be able to tolerate 
the discomfort related to the removal of the fillings, she 
took large doses of cortisone for 3 weeks each time. 
Psychotherapeutic Treatment. For almost 4 years, 
XX has rested systematically. Meditation and rest in the 
form of mental control and relaxation have been 
important. This has gradually helped her get better 
because according to her, “the body has economized on 
the neurotransmitters which the nerves are supposed 
to bring to the muscles.” XX did not want to stop work-
ing, even though she understood that the job drained 
her of the little energy she had. The realization that she 
had to spend all her energy on herself in order to have 
a chance of getting better has been very important for 
her. Now she spends most of her time with her family. 
She is able to make herself and her own health a prior-
ity without feeling guilty. 
other Measures. In consultation with BB, XX has 
changed her diet according to advice from the MS cen-
ter at a Norwegian hospital. She first omitted red meat, 
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fat, and dairy products and later omitted sugar and 
yeast, artificial sweeteners, and natural sugars. 
ouTCoMes
Medical assessment
MS and cancer cases in the Registry are assessed by 
medical doctors. Medically exceptional courses of dis-
ease are defined as courses occurring with less than 1% 
probability after the given conventional treatment based 
on current medical knowledge. The assessment of this 
case concluded, “Interesting description of Dr. Brunes’ 
treatment and the experienced effects of this. This is, 
however, not a medically exceptional course of disease.”
Patient’s Perspective
XX thinks that the CAM treatment consisting of vita-
mins and minerals from the health food store along with 
“mind control” in the form of meditation and positive 
thinking support the conventional medical treatment 
included in BBs’ treatment model. The patient writes, 
The supplements administer my immune system 
and the rest of my physical health, which again 
makes me stronger and helps me handle my MS bet-
ter. . . . The reason why I experience my MS-course 
as exceptionally positive is that many of my symp-
toms that according to my neurologist were irrevers-
ible, now are gone or have been greatly reduced. I 
have a sense of touch in all fingers and toes and 
under the whole soles of my feet. Four years ago I 
was numb to my knees and sometimes all the way 
to my chest. I have more energy, can do more things 
myself, and I do not need to rest the whole day. I 
have much more control of the bladder. Going to the 
bathroom 13 to 16 times per 24 hours has now been 
reduced to about half of this. I have also learnt to 
handle the disease and to have a positive outlook on 
life. I am no longer melancholic. I actually feel that 
my life has never been as good as it is now, in spite of 
the many limitations caused by the disease.
follow-up Care
XX can contact BB by phone whenever she feels 
the need for follow-up care. 
Confidentiality and informed Consent
The Regional Committee for Medical and Health 
Research Ethics and the Norwegian Data Inspectorate 
have approved the Registry. The patients have given 
their informed consent. Information that could identi-
fy the patient in this case report has been avoided. The 
patient has read and approved the case report.
DisCussion
BB and her treatment model have been criticized 
because the treatment is unconventional and expensive 
and the outcomes have not been validated through 
clinical studies.16 BB’s treatment model includes a holis-
tic and psychosocial medical approach to MS treatment. 
Many arguments have been raised for a more patient-
centered and biopsychosocial medicine to optimize and 
safeguard modern patients’ treatment decisions and 
treatment outcomes.17,18 A qualitative study of patients’ 
experiences and reflections with regard to their reported 
“best cases” of MS in the Registry found that these 
patients, independently of treatment systems, changed 
over time their position from passive recipients of con-
ventional health care to explorers of healthcare. The 
concept of “explorer” implies action and entails all the 
social, cultural, and economical capital19 needed by the 
patients to take responsibility for and cope with their 
situations. As explorers, the patients, like XX in this case 
report, influence how an intervention is chosen and 
used. CAM facilitates the patients’ own efforts that 
patients believe are needed for improved health and 
well-being in their lives with MS.13
ConClusion
A holistic and psychosocial medical approach to 
MS treatment, including hope and the ability for the 
patient to cope, was of vital importance to XX’s positive 
outcome of the MS treatment presented in this case 
report. The patient-experienced benefits of CAM 
reported in “best cases” so far generate unexplored and 
complex questions worthy of further research. 
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